Added to YB: 2019-12-17
Pitch date: 2019-12-17
BMY RT [bullish]
Bristol-Myers Squibb Company
+17.89%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Market Cap
N/A
Pitch Price
$49.31
Price Target
N/A
Dividend
4.41%
EV/EBITDA
7.85
P/E
16.00
EV/Sales
3.14
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Bristol-Myers Squibb CVR BMY RT
A summary for this pitch has not been created yet.
Read full article (0 min)